Study of BT02 for advanced lung cancer
Treatments studied
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a new drug called BT02 for people with advanced lung cancer who have already tried other treatments. It aims to see if BT02 is safe and effective for non-small cell or small cell lung cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced non-small cell or small cell lung cancer that has spread or come back after treatment.
- You have at least one tumor that can be measured on a scan outside the brain.
- You can take care of yourself (ECOG score 0 or 1) and are expected to live at least 3 months.
- You do not have a targetable gene mutation or fusion in your cancer.
- You have not had cancer treatment or major surgery in the last 4 weeks, and no active autoimmune disease in the last 2 years.
- You agree to use effective birth control during the study if you or your partner can have children.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new cell therapy (BST08) for people with advanced non-small cell lung cancer that has not improved after at least two prior treatments. The treatment is made from a sample of your own tumor, so it may be a personalized option for you.
This Phase 2 study tests a combination of two experimental medicines in people with advanced or metastatic solid cancers, including non-small cell lung cancer and nasopharyngeal cancer. It aims to see whether the drugs can shrink tumors and improve outcomes, while carefully checking safety and eligibility.
This Phase 2 trial tests how well two study drugs (and a combination of them) work in people with extensive-stage small cell lung cancer. It’s mainly for patients whose cancer has come back or who couldn’t tolerate at least some standard treatments, and it aims to see if treatment can shrink tumors and be tolerable.
This trial tests a new combination of two investigational drugs, BNT324 and BNT327, for people with advanced lung cancer that cannot be removed by surgery. It aims to see if the combination is safe and effective for different types of lung cancer, including non-small cell and small cell lung cancer.
This trial tests a new drug, BL-M09D1, in people with advanced non-small cell lung cancer or other solid tumors that have not responded to standard treatments. The goal is to see if the drug can help shrink or control the cancer.
This trial tests a new drug, BA1302, for people with advanced solid tumors that have stopped responding to standard treatments. The study aims to see if BA1302 is safe and effective.
Hear when a new Advanced Malignant Solid Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.